RGS5 and neoplasm: Using scRNA-seq on tumor samples and para-tumor samples from bladder carcinoma and the sequencing data from TCGA, investigators found that the iCAF-specific marker PDGFRA was associated with poor overall survival while the myo-cancer-associated fibroblast marker RGS5 was not [54].